Retired Two-Star Marine Corps Major General Arnold Punaro, Former Staff Director of the Senate Armed Services Committee discusses Pete Hegseth's confirmation hearing. He is joined by Bloomberg's Joe Mathieu and Kailey Leinz.

See omnystudio.com/listener for privacy information.

Union Square Hospitality Group Chairman/Founder Danny Meyer and PreciTaste AI CEO Ingo Stork speak on the growing trend of AI use in the restaurant industry. They speak with Bloomberg's Caroline Hyde.

See omnystudio.com/listener for privacy information.

GE HealthCare President and CEO Peter Arduini discusses the company’s $1 billion imaging deal with Sutter Health and the future of AI in the health-care industry. He speaks with Bloomberg's Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco.

See omnystudio.com/listener for privacy information.

Goldman Sachs Chief Economist Jan Hatzius discusses gradual tariff hikes, the case for pause in rate cuts, and the strong jobs report with Bloomberg's Minmin Low.

See omnystudio.com/listener for privacy information.

Republican Representative Nicole Malliotakis of New York discussed the meeting she and other lawmakers had with President-elect Donald Trump at Mar-a-Lago and the chances of increasing the state and local tax deduction. She speaks with Bloomberg's Joe Mathieu and Kailey Leinz.

See omnystudio.com/listener for privacy information.

Eli Lilly Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill could be approved in early 2026. He speaks to Bloomberg's Katie Greifeld from the JPMorgan Healthcare Conference in San Francisco.

See omnystudio.com/listener for privacy information.

US National Security Advisor Jake Sullivan said there’s a “distinct possibility” that Israel and Hamas will be able to reach a ceasefire deal before President Joe Biden leaves office in a week. Sullivan spoke about this and a wide range of subjects in Washington with Bloomberg's Jenny Leonard.

See omnystudio.com/listener for privacy information.

Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.

He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

See omnystudio.com/listener for privacy information.